(Circulation. 1997;95:1601-1610.)
© 1997 American Heart Association, Inc.
Articles |
From the Cardiology Division and Gazes Cardiac Research Institute (M.K., M.N., M.R.Z., G.D., H.T., G.C., B.A.C.) and the Department of Comparative Medicine (M.M.S., G.K.), Medical University of South Carolina, Charleston, and the Ralph H. Johnson Department of Veterans Affairs (M.R.Z., G.C., B.A.C.), Charleston, SC.
Correspondence to Blase A. Carabello, MD, Cardiology Division, Medical University of South Carolina, 171 Ashley Ave, Charleston, SC 29425-2221.
| Abstract |
|---|
|
|
|---|
Methods and Results We recently developed a model of
gradual proximal aortic constriction in the adult canine that mimicked
the heterogeneity of the hypertrophic response seen in humans. We
hypothesized that differences in outcome were related to differences
present before banding. Fifteen animals were studied initially. Ten
developed left ventricular dysfunction (dys group). Five dogs
maintained normal function (nl group). At baseline, the nl group had a
lower mean systolic wall stress (96±9 kdyne/cm2; dys
group, 156±7 kdyne/cm2; P<.0002) and greater
relative left ventricular mass (left ventricular weight [g]/body wt
[kg], 5.1±0.36; dys group, 3.9±0.26; P<.02). On the
basis of differences in mean systolic wall stress at baseline, we
predicted outcome in the next 28 dogs by using a cutoff of 115
kdyne/cm2. Eighteen of 20 dogs with baseline mean systolic
stress >115 kdyne/cm2 developed dysfunction whereas 6 of 8
dogs with resting stress
115 kdyne/cm2 maintained normal
function.
Conclusions We conclude that this canine model mimicked the heterogeneous hypertrophic response seen in humans. In the group that eventually developed dysfunction there was less cardiac mass despite 60% higher wall stress at baseline, suggesting a different set point for regulating myocardial growth in the two groups.
Key Words: hypertrophy stenosis ventricles aorta heart failure valves
| Introduction |
|---|
|
|
|---|
If the amount of left ventricular hypertrophy that developed responded to load perfectly so that wall stress was normalized, then there would be just enough increase in wall thickness to offset the increase in pressure. However, in many instances, the hypertrophy that develops is inadequate to maintain normal wall stress; wall stress increases and ejection performance falls.3 4 In some such cases, contractile dysfunction develops (pathological hypertrophy) in addition to afterload being increased.4 In other cases there is "excessive" hypertrophy producing subnormal wall stress and supernormal ejection performance.5 6
The question addressed in this study is, why does a pressure overload cause the disparate myocardial responses noted above? Are these differences in response based on differences in the loadits magnitude, time course, duration, etcor are these differences predicated on inherent differences in the myocardial response to the overload? Is there a different set point or threshold for stress to activate the hypertrophic process? In humans, years of observation of a large number of patients would be required to correlate differences in the disease process with differences in outcome with regard to myocardial hypertrophy in an effort to answer the questions posed above. However, we recently developed a model of gradual ascending aortic constriction in the adult dog. In this model, the band is applied identically to each subject, making it unlikely that differences in outcome are due to differences in the "disease" process. In our early experience with this model, we noted that similar to humans, some mongrel outbred purpose-bred dogs developed extensive left ventricular hypertrophy with normal or even supernormal left ventricular performance while other animals of similar weight, sex, and breeding developed less extensive hypertrophy and subsequently acquired left ventricular dysfunction. Since the banding technique and pressure gradient were nearly identical from animal to animal, it suggested that differences in outcome were predicated on individual differences in the response of the myocardium to the pressure overload. If that were so, we hypothesized that there might already be individual differences in the myocardial response to the existing load in the normal state before banding. If so, those differences, when found, should make the eventual outcome of banding predictable. We tested this hypothesis by retrospectively examining the baseline data for animals for which the outcome was known and then validated the importance of the differences found by using them to predict outcome in a second prospectively analyzed series of dogs.
| Methods |
|---|
|
|
|---|
Prospective Studies
Differences between the group of dogs with ventricular
dysfunction and the group with normal function were then used to
prospectively predict functional outcome in 28 additional dogs. Thus,
in all, 43 dogs were studied.
At all times the standards of care for the animals met or exceeded those of the American Physiological Society and the American Association for Accreditation of Laboratory Animal Care.
Assessment of Contractile Function
Hemodynamic studies were performed in both the ß-blocked and
unblocked state at all five observations. ß-Blockade was used so that
innate contractile function could be studied in the absence of
adrenergically mediated changes in contractility. Unblocked
hemodynamics was studied to better estimate ambient hemodynamic
conditions such as gradient. Thus, when we report ventricular
performance data (mean normalized ejection rate, ejection fraction,
etc) and wall stress used in evaluating contractile function, these
data were obtained on ß-blockade. All other data are from
measurements made off ß-blockade. Contractile function was assessed
by plotting mean normalized systolic ejection rate
(MNSER)9 against mean systolic midwall stress (MSS), using
data acquired during ß-blockade. This relationship is a modification
of the technique that plots the mean velocity of circumferential fiber
shortening (Vcf) against wall stress.10 Mean normalized
systolic ejection rate is ejection fraction divided by ejection time,
whereas mean velocity of circumferential fiber shortening is shortening
fraction divided by ejection time. Both use a relatively
preload-independent parameter (MNSER or Vcf)11 and
normalize it for afterload, yielding a measure of contractile function.
The MNSER-MSS relation and its 95% confidence limits were plotted for
40 normal dogs previously studied on ß-blockade in our laboratory.
Animals in the current study falling down and to the left of the lower
confidence limit were defined as having systolic contractile
dysfunction. Because MNSER reflects endocardial shortening, which might
overestimate total myocardial performance,12 modified
midwall fiber shortening rate was also plotted against mean systolic
midwall stress.
Model for Inducing Gradual Aortic Constriction
Since sudden pressure overload may cause acute myocardial
damage13 and since most human pressure overloads develop
gradually, it is preferable that pressure overload models induce the
overload gradually. Many previous models produced gradual constriction
by banding the pulmonary artery or aorta in juvenile animals.
Subsequent growth produced gradually increased pressure overload as
cardiac output increased through the fixed obstruction. However,
juvenile hypertrophy may differ from adult hypertrophy.14
In this study, adult dogs were banded by the investigators who
perfected the model (M.K., M.N.). Anesthesia was induced with an
intravenous injection of a mixture of fentanyl and droperidol (0.5
mL/kg). The dogs then were intubated and mechanically ventilated.
Anesthesia was maintained with inhalation of a mixture of 1% to 1.5%
isoflurane, nitrous oxide, and oxygen. Two 5.2F pigtail catheters were
inserted into the left femoral artery and advanced to monitor left
ventricular pressure and descending aortic pressure simultaneously. A
right thoracotomy was made through the third intercostal space. The
pericardium was opened and the ascending aorta was exposed. To provide
exposure of the aortic root, the right atrial appendage was retracted
caudally. We used extreme care to avoid vasa vasoral damage; periaortic
fat was dissected posteriorly 1 cm below the subclavian artery to make
a small tunnel for passage of the band. A PTFE tube (6-mm diameter,
Impra Inc) was placed around the ascending aorta through the tunnel and
then two 9-mm-wide polyester umbilical tapes (Nittyo Kogyo Inc) were
threaded through the PTFE tube. The PTFE tube protected the aortic wall
from the edges of the band, which could have been a focal point for
aortic rupture. The band was then inserted through a silicone stent and
tied around a balloon dilatation catheter so that inflation of the
catheter tightened the band, in turn constricting the aorta (Fig 1
). The stent was separated from the aorta by
a convex silicone "protector," which allowed the force of the
constricting band to be diffused over a large area of the aorta instead
of concentrated at the edges of the stent. Mattress sutures of 3-0
prolene were placed on the band ends to fix them around the balloon.
The balloon was inflated with saline to test the system and to produce
a peak pressure gradient across the band of 30 mm Hg. The
inflation port of the balloon catheter was sealed with a rubber cap and
placed in a subcutaneous pocket on the neck or back. The chest was
closed, and the dogs recovered from anesthesia and were followed on a
standard diet under close veterinary supervision.
|
Catheterization Protocol
All five studies were performed during light anesthesia, using a
mixture of fentanyl-droperidol given intravenously and inhalation of
nitrous oxideoxygen at a ratio of 3:1. This combination has been
demonstrated to have little effect on contractile
function.15 At the baseline study, a cutdown was performed
over the carotid artery from which catheters were introduced into the
left ventricle and ascending aorta. At 2, 4, and 6 weeks and at the
final study, catheters were introduced into the left ventricle and
aorta through a femoral artery cutdown. The studies were performed
identically at each time period. Left ventricular pressure and aortic
pressure were recorded simultaneously while a left ventriculogram was
performed in the 30° right anterior oblique position at 60 frames per
second by injection of nonionic radiographic contrast. Then,
ß-blockade was induced by infusion of a loading dose of esmolol (0.5
mg/kg per minute for 3 minutes) followed by a constant infusion at a
dose of 0.3 mg/kg per minute. A second ventriculogram was then
performed in the same fashion as the first. The ventriculograms and the
pressure recordings were used to calculate ejection fraction, MNSER,
and left ventricular mass, volume, and wall stress frame-by-frame.
Augmentation of Pressure Overload
Pressure overload was augmented at 2 weeks, 4 weeks, and 6 weeks
of the study as follows. After discontinuation of ß-blockade followed
by a 20-minute recovery period, the balloon of the aortic constriction
system was inflated by injection of saline through the injection port.
The balloon was inflated slowly to increase the gradient of 30
mm Hg present after banding to a target pressure gradient of 60
mm Hg at 2 weeks, 90 mm Hg at 4 weeks, and 120 mm Hg at 6
weeks. To confirm that the 2-week interval between pressure gradient
increases was adequate for full development of hypertrophy, 6 study
dogs underwent daily echocardiograms. Fig 2
demonstrates that left
ventricular muscle mass as measured by cross-sectional area increased
over the first 9 days and then plateaued.
Thus, the hypertrophy of these left ventricles appeared to be
completely developed before the next pressure increase occurred.
|
Isolated Cardiocyte Function
One week after the final in vivo evaluation of left ventricular
function, cardiocytes were isolated and cardiocyte contractile function
was measured as previously described.8 The dogs were
deeply anesthetized. The pericardium was excised, and the heart was
rapidly removed and placed in a cold calcium-free buffer. A wedge of
the left ventricle supplied by the circumflex artery was isolated, and
the artery was cannulated and perfused with collagenase. Then the
tissue was minced into 2-mm cubes and was gently agitated for 5 minutes
at 37°C while being gassed with 100% O2. The cardiocytes
were harvested by drawing off the supernatant in which they were
suspended for filtration through 210-µm nylon mesh. Laser diffraction
was then used to analyze the extent and velocity of sarcomere
shortening. The cardiocytes were stimulated to contract between
platinum wire electrodes. Changes in sarcomere length were measured
from the movement of the first-order diffraction pattern cast by a
substage laser light passing through the sarcomeres of a given
cardiocyte onto diametrically opposed optical sensors situated above
the microscope stage. Only cardiocytes that were single, rod-shaped,
unattached to adjacent cells, and that contracted with each stimulus
but were quiescent between stimuli were studied. Cardiocyte data from 8
previously unreported normal dogs served as control data.
Calculations
Left ventricular volumes were calculated by the area-length
method. Left ventricular mass was calculated by the method of Rackley
et al,16 which has previously been demonstrated to produce
accurate volumes and masses in our laboratory.17 Our
ventriculographic mass calculations were corroborated by calculations
made from echocardiographic images as we have described
before.18 Left ventricular wall stress (
) was
calculated using Mirsky's formula19 and methods we have
used previously.5 17 MSS was derived by averaging the
stress calculated frame-by-frame during systole. MNSER was calculated
as ejection fraction divided by ejection time. Left ventricular
contractile function on ß-blockade was inferred by plotting the
MNSER-MSS relationship of a given animal at a given observation period
against the confidence limits of the relationship derived from 40
normal dogs studied during ß-blockade. Modified midwall fiber
shortening velocity (midwall mVcf) was calculated as previously
described12 (see "Appendix").
Statistics
All the data are expressed as SEM. The normal MNSER-MSS and
modified midwall Vcf-MSS relationships were derived using least-squares
linear regression analysis. For the analysis of daily increase in the
cross-sectional area of the left ventricle, piecewise linear
regression20 was used to search for changes in the rate of
development of hypertrophy. Comparison of differences in sarcomere
shortening velocity among the three groups was analyzed with ANOVA, and
a Newman-Keuls test was used to determine individual differences. When
grouped baseline data were compared, an unpaired t test was
used. Comparisons of overall differences between the two groups over
time were analyzed with ANCOVA.
| Results |
|---|
|
|
|---|
|
|
|
Left Ventricular Wall Stress, Performance, and Hypertrophy
The transconstriction pressure gradient recorded off ß-blockade
at each observation period is demonstrated for both groups of dogs in
Fig 5
. Mean normalized systolic ejection rate
on ß-blockade is plotted for the entire course of the study in Fig 6
. It was maintained at baseline values in
the normal group throughout the study but declined sharply at 6 weeks
in the dysfunction group. Likewise, ejection fraction declined from
0.58±0.02 to 0.51±0.03 in the dysfunction group (P<.05)
but was maintained in the normal group (0.72±0.03, baseline;
0.77±0.03, final study). Mean left ventricular systolic wall stress
calculated from measurements made off ß-blockade and left ventricular
mass are demonstrated for both groups of dogs throughout the course of
the study in Fig 7
. In the group that
maintained normal function, left ventricular wall stress was less and
mass was greater than in the group that developed dysfunction. Gross
pathology sections from representatives of each group demonstrating the
different patterns of hypertrophy are shown in Fig 8
.
|
|
|
|
Prospective Studies
Of the differences between the groups of dogs shown in Table 1
,
the difference in mean systolic wall stress was striking and
statistically the most significant. After analyzing initial mean stress
off ß-blockade, we picked a cutoff value for mean stress of 115
dyne/cm2x103. Eighteen of 20 dogs with a
baseline MSS of
115 kdyne/cm2 developed dysfunction,
whereas 6 of 8 dogs with a baseline MSS
115 kdyne/cm2 had
normal function. The baseline MSS of all 43 dogs in relationship to
left ventricular dysfunction at 8 weeks is shown in Fig 9
. As can be seen, 11 of 13 dogs with MSS
115 kdyne/cm2 had normal function, whereas 28 of 30 dogs
with MSS >115 kdyne/cm2 developed dysfunction.
|
The baseline differences in stress and left ventricular mass between
the groups might have biased the outcome in a self-fulfilling prophecy.
That is, the lower mass and higher stress in the high stress group may
have created an automatic "disadvantage," causing these hearts to
develop failure because they began the study with lower mass to begin
with. To address this problem, we banded 3 dogs with high stress (in
which ventricular dysfunction was predicted to occur) to a slightly
higher initial gradient (50 mm Hg) than the usual protocol.
Within 1 week, left ventricular masstobody weight ratio had
increased to 4.7±0.3, not different from that of the normal function
group at baseline. Left ventricular function was normal at that time.
The gradient was then decreased so that wall stress fell to that of the
normal function group and remained so at 2 weeks (Fig 10
). Thus, at this point in time, this
manipulated group of 3 dogs initially predicted to develop dysfunction
now had wall stress and left ventricular mass similar to the group that
eventually maintained normal function. From there, the protocol was
followed in normal fashion. By 8 weeks, wall stress in the manipulated
group increased to that of the initial dysfunction group, and all 3
stress-manipulated dogs developed left ventricular dysfunction.
|
Baseline Reproducibility
Because our study relied heavily on differences detected at
baseline, we repeated the baseline study 1 week later in 14 dogs and
compared the two baseline results (Table 2
).
Selected parameters are demonstrated in Table 2
. Naturally, some
variation existed, but the differences were neither clinically nor
statistically significant.
|
| Discussion |
|---|
|
|
|---|
We believe that our findings are of interest because they are so similar to those that occur in human adults who acquire aortic stenosis. Many patients demonstrate afterload mismatch, a situation in which hypertrophy is inadequate to normalize systolic wall stress; such patients often develop left ventricular muscle dysfunction.3 4 On the other hand, there are patients with exuberant hypertrophy, reduced wall stress, and excellent ejection performance.6 These patients are typified by our group of dogs that maintained normal contractile function throughout the study. Indeed, these dogs had an average ejection fraction of 77% at the end of the study.
To our knowledge this is the first time that these baseline
observations and their correlation with the response to pressure
overload have been made in either experimental or human aortic
stenosis. In human studies of aortic stenosis, the results of the
pressure overload have been examined only after the load has been well
established. The reasons for this are obvious. There would be no cause
to study patients prospectively at the time when they were normal,
since such patients would not have come under clinical scrutiny.
Likewise, in most animal studies of pressure overload, the effect of
the overload was studied only after the pressure overload caused muscle
dysfunction. In one longitudinal study, Sasayama and
colleagues21 did examine the effects of modest pressure
overload that produced
20% left ventricular hypertrophy and normal
left ventricular function. Since dysfunction never developed, it was
not possible to examine differences between animals with normal
function and animals with dysfunction. Aoyagi and
colleagues22 recently followed banded sheep longitudinally
from when contractile function was normal through the development of
intrinsic contractile dysfunction. The results of their study and ours
were similar in that both found a period of compensated hypertrophy
before dysfunction developed. However, our study differs from theirs in
that we found two distinct groups of animals with different
hypertrophic responses and different functional outcomes.
We should point out that at the time when the animals were normal, it obviously was impossible to weigh the hearts and at no time during an in vivo study was it possible to directly measure wall stress. Thus, baseline mass and stress, two major properties upon which our conclusions rest, were calculated rather than directly measured. However, we have established accurate mass calculations made from echocardiograms or ventriculograms validated by mass weighed after the animals were euthanatized in our laboratory.17 18 Accurate mass calculation requires accurate measurement of dimensions and thickness. Since these are the same dimensions from which wall stress is calculated (when pressure is added), accurate mass calculation helps validate our ability to calculate stress.
Extent of Hypertrophy Versus Left Ventricular Dysfunction
In previous experimental studies of pressure overload induced by
outflow obstruction, there has been a rough positive correlation
between the extent of hypertrophy and the development of left
ventricular dysfunction, with dysfunction occurring when the
hypertrophy was severe. However, a partial summary (Table 3
) of studies
of function in hypertrophy demonstrates many exceptions to this
concept.21 22 23 24 25 26 27 28 29 For instance,
contractile function was normal in one group of animals with 123%
hypertrophy26 yet abnormal in another group with less
hypertrophy (45%)24 but also abnormal in the group with
more hypertrophy (150%).29 These data suggest that the
development of left ventricular dysfunction is not based simply on
developing extensive hypertrophy. Indeed, in the present study, the
animals with the most hypertrophy had normal function whereas those
with less hypertrophy had muscle dysfunction. As noted above, these
traits also may be seen in humans.3 4 5 6 These studies
suggest that hypertrophy can be compensatory regardless of extent. In
fact, it can be speculated from our data that it is when hypertrophy is
inadequate to normalize wall stress that the transition to pathological
hypertrophy occurs.
|
Assessment of Contractile Function: Correlation of In Vivo and In
Vitro Measurement
In this study, the presence or absence of contractile dysfunction
was used as the key variable for dichotomizing the groups of dogs
because it is the presence of muscle dysfunction that helps distinguish
pathological from adaptive hypertrophy. The assessment of contractile
function in vivo has been fraught with difficulty. The perfect index of
contractility would be independent of load, independent of left
ventricular mass and size, and sensitive to changes in contractile
function. In previous studies we have used an inferior vena cava
balloon to alter pressure and volume to construct various indexes of
contractility.7 8 This technique was not used in the
current studies because we feared that balloon-induced hypotension
might cause ischemia in the pressure-overloaded myocardium
known to be at risk for ischemia.30 31 32 Therefore,
we used the relationship of mean normalized systolic ejection rate and
wall stress to infer contractile function. Mean normalized systolic
ejection rate is similar to mean velocity of circumferential fiber
shortening except that it relies on volumes rather than dimensions. As
such, this index could be expected to be dependent on contractile
function and afterload but reasonably independent of
preload.11 Since ejection fraction is dimensionless, this
index is size-independent, unlike maximal systolic elastance, which
varies inversely with ventricular volume.33 By plotting
MNSER against afterload (wall stress), an index that is dimensionless
and relatively preload independent that incorporates afterload into its
expression is produced. We and others have used this paradigm
successfully to assess contractile function in the
past.10 29 Importantly, our in vivo findings were
corroborated by indexes of cell contractile function measured by
investigators in our group, who were blinded to our results. This
collaboration gave us the opportunity to corroborate the in vivo
measurement with another standard of contractile function-the function
of the cardiocytes isolated from the left ventricle that had been
evaluated in vivo. Such corroboration helps strengthen our own
conclusions and helps lend credence to past studies of in vivo
contractile function performed by others using similar indexes in which
a second standard of contractile function was unavailable. These
studies further suggest that when ventricular contractile dysfunction
is present, it is at least in part a property of the cardiocytes
comprising the chamber as opposed to other chamber factors such as
geometry, collagen deposition, etc.
Model of Pressure Overload
The hypertrophy that develops in experimental overload must be
viewed in the context of the model that produces it. Models of right
ventricular pressure-overload hypertrophy and left ventricular
pressure-overload hypertrophy have been developed in the adult and
juvenile animals. In juvenile animals, a fixed band is placed around
the pulmonary artery or aorta, and as the animal grows the pressure
overload gradually worsens. These models have the advantage of
producing gradually induced overload such as might occur in humans but
have the disadvantage of producing the hypertrophy in juveniles in
which hypertrophy might be different from that which occurs in
adults.14 34 While it is important to study juvenile
hypertrophy, which affects many children with congenital heart disease,
adult models probably should be studied if it is the pathophysiology of
the adult that is sought. However, most previous adult models have used
an initial fixed constriction, which, if mild, produces only mild
pressure overload or if severe may cause sudden pressure overload,
potentially producing myocardial damage.13 This damage may
introduce artifact into the experimental results. Acute overload is
also at variance with most pressure overload in adults in which it is
acquired gradually rather than suddenly. Our model is specifically one
of gradually developing hypertrophy in the adult canine. It overcame
previous problems with aortic rupture, a specific problem in dogs, and
allowed longitudinal study of the animals.
We conclude that in this model of gradually applied left ventricular pressure overload in the adult dog that outcome is predicated to a large extent on baseline differences in mass and wall stress that occur naturally in normal dogs and not to differences in the rate or the amount of pressure overload. These differences may be genetically mediated. The dogs that developed extensive hypertrophy and maintained normal function had higher ventricular mass despite lower wall stress at baseline, suggesting they were already responding differently to their ambient load than the animals that developed less hypertrophy and muscle dysfunction.
| Acknowledgments |
|---|
| Appendix 1 |
|---|
|
|
|---|
![]() | (1) |
At a specific time in the cardiac cycle,
![]() | (2) |
![]() | (3) |
![]() | (4) |
![]() | (5) |
![]() | (6) |
Assuming that the volume of each shell remains constant throughout the
cardiac cycle,
![]() | (7) |
![]() | (8) |
To calculate midwall mean Vcf,
![]() | (9) |
![]() | (10) |
![]() | (11) |
![]() | (12) |
![]() | (13) |
Received July 15, 1996; revision received October 23, 1996; accepted November 18, 1996.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
D. Scholz, P. McDermott, M. Garnovskaya, T. N. Gallien, S. Huettelmaier, C. DeRienzo, and G. Cooper IV Microtubule-associated protein-4 (MAP-4) inhibits microtubule-dependent distribution of mRNA in isolated neonatal cardiocytes Cardiovasc Res, August 1, 2006; 71(3): 506 - 516. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Berenji, M. H. Drazner, B. A. Rothermel, and J. A. Hill Does load-induced ventricular hypertrophy progress to systolic heart failure? Am J Physiol Heart Circ Physiol, July 1, 2005; 289(1): H8 - H16. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yamaguchi, J. Yoshida, K. Yamamoto, Y. Sakata, T. Mano, N. Akehi, M. Hori, Y.-J. Lim, M. Mishima, and T. Masuyama Elevation of plasma brain natriuretic peptide is a hallmark of diastolic heart failure independent of ventricular hypertrophy J. Am. Coll. Cardiol., January 7, 2004; 43(1): 55 - 60. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Braunwald Congestive heart failure: a half century perspective Eur. Heart J., May 2, 2001; 22(10): 825 - 836. [PDF] |
||||
![]() |
M. Koide, M. Hamawaki, T. Narishige, H. Sato, S. Nemoto, G. DeFreyte, M. R. Zile, G. Cooper IV, and B. A. Carabello Microtubule Depolymerization Normalizes In Vivo Myocardial Contractile Function in Dogs With Pressure-Overload Left Ventricular Hypertrophy Circulation, August 29, 2000; 102(9): 1045 - 1052. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Nagatomo, B. A. Carabello, M. L. Coker, P. J. McDermott, S. Nemoto, M. Hamawaki, and F. G. Spinale Differential effects of pressure or volume overload on myocardial MMP levels and inhibitory control Am J Physiol Heart Circ Physiol, January 1, 2000; 278(1): H151 - H161. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Laine, C. Katoh, M. Luotolahti, H. Yki-Jarvinen, I. Kantola, A. Jula, T. O. Takala, U. Ruotsalainen, H. Iida, M. Haaparanta, et al. Myocardial Oxygen Consumption Is Unchanged but Efficiency Is Reduced in Patients With Essential Hypertension and Left Ventricular Hypertrophy Circulation, December 14, 1999; 100(24): 2425 - 2430. [Abstract] [Full Text] [PDF] |
||||